In past decades, a rapid evolution of diabetes technology led to increased popularity and use of continuous glucose monitoring (CGM) and continuous subcutaneous insulin infusion (CSII) in the ambulatory setting for diabetes management, and recently, the artificial pancreas became available. Efforts to translate this technology to the hospital setting have shown accuracy and reliability of CGM, safety of CSII in appropriate populations, improvement of inpatient glycemic control with computerized glycemic management systems, and feasibility of inpatient CGM-CSII closed-loop systems. Several ongoing studies are focusing on continued translation of this technology to improve glycemic control and outcomes in hospitalized patients.
Diabetes Technology in the Inpatient Setting for Management of Hyperglycemia.
Georgia M. Davis,Rodolfo J. Galindo,A. Migdal,G. Umpierrez
Published 2020 in Endocrinology and metabolism clinics of North America (Print)
ABSTRACT
PUBLICATION RECORD
- Publication year
2020
- Venue
Endocrinology and metabolism clinics of North America (Print)
- Publication date
2020-03-01
- Fields of study
Medicine, Engineering
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-53 of 53 references · Page 1 of 1
CITED BY
Showing 1-47 of 47 citing papers · Page 1 of 1